“ralph-whitworth” Archives

in
Entry Author Date Location
West Coast Biotech Roundup: Theranos, Medivation, Juno, and More 04/15/16 San Francisco
Dendreon Faces Internet-Fueled Shareholder Uprising, Led by a Little Guy in Kansas 04/01/11 Seattle
Genzyme Agrees to Sell Genetics Unit to LabCorp for $925M 09/13/10 Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis? 07/29/10 Boston
Genzyme Stock Surges 15 Percent on Sanofi Buyout Speculation 07/23/10 Boston
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote 06/09/10 Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders 05/13/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Genzyme Adds Whitworth to Board, Agrees to Add One More Director to Activist’s Liking 04/15/10 Boston
Genzyme Adds Whitworth to Board, WSJ Says 04/14/10 Boston
Ralph Whitworth on What Must Change at Genzyme, Verari Starts Anew, V-Vehicle Tries to Keep it Stealthy, & More San Diego BizTech News 01/25/10 San Diego
VentiRx Pharmaceuticals Raises More Funds, Genzyme Declares a Truce, Adventrx Charts Comeback, & More San Diego Life Sciences News 01/14/10 San Diego
Genzyme Reaches Agreement with Activist Investor, Charles River Closes Shrewsbury Lab, Lycera Comes to Cambridge, & More Boston-Area Life Sciences News 01/13/10 Boston
Agreement Between Genzyme and San Diego Activist Shareholder Suggests Truce 01/07/10 San Diego
Page 1 of 1